United States · Funded startup

Who invested in Intra-Cellular Therapies

3 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 31 Oct 2026

$135Mraised across 3 rounds since 2013, from 3 sources

$15MDebt$60MGrowth$60MSecondary
Latest round
Secondary, $60MSept 2013
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2014
$15MDebt$60MGrowth$60MSecondary
First round
Debt, $15M
May 2013
Biggest round
$60M
Secondary · Sept 2013
Between rounds
3 months
from the last two

The rounds

  1. Sept 2013
    Secondary$60M2 new

    From a historical funding recordSEC filing: $60M sold, first sale Aug 2013

  2. Aug 2013
    Growth$60M

    No investor was named in the report.

    Reported by sec.govSEC filing: $60M sold, first sale Aug 2013

  3. May 2013
    Debt$15M

    No investor was named in the report.

    Reported by sec.govSEC filing: $15M sold, first sale Oct 2012

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Debt2013Growth2013Secondary2013DeerfieldBroadfin Capital

Everyone who backed them

DeerfieldVC firm1round
Broadfin CapitalInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Intra-Cellular Therapies

Who invested in Intra-Cellular Therapies?

Intra-Cellular Therapies's investors include Deerfield and Broadfin Capital.

How much has Intra-Cellular Therapies raised?

Intra-Cellular Therapies has raised $135M across 3 rounds since 2013.

When did Intra-Cellular Therapies last raise?

Intra-Cellular Therapies's most recent round was a Secondary of $60M in Sept 2013.

What was Intra-Cellular Therapies's biggest round?

Its most recent round, $60M in Sept 2013, is also its largest on record.

Who backed Intra-Cellular Therapies first?

Intra-Cellular Therapies's first round on record, in Sept 2013, was backed by Deerfield and Broadfin Capital.

What stage is Intra-Cellular Therapies at?

Intra-Cellular Therapies's latest named round is a Secondary, in Sept 2013.

Where is Intra-Cellular Therapies based?

Intra-Cellular Therapies is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.